apremilast [Ligand Id: 7372] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL514800 (Apremilast, CC-10004, CC10004, Otezla)
  • phosphodiesterase 4B/Phosphodiesterase 4B in Human [ChEMBL: CHEMBL275] [GtoPdb: 1301] [UniProtKB: Q07343]
There should be some charts here, you may need to enable JavaScript!
  • phosphodiesterase 4D/Phosphodiesterase 4D in Human [ChEMBL: CHEMBL288] [GtoPdb: 1303] [UniProtKB: Q08499]
There should be some charts here, you may need to enable JavaScript!
  • phosphodiesterase 4A in Human [GtoPdb: 1300] [UniProtKB: P27815]
There should be some charts here, you may need to enable JavaScript!
  • phosphodiesterase 4C in Human [GtoPdb: 1302] [UniProtKB: Q08493]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
phosphodiesterase 4B/Phosphodiesterase 4B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL275] [GtoPdb: 1301] [UniProtKB: Q07343]
ChEMBL Inhibition of human PDE4B using [3H]cAMP as substrate incubated for 5 mins followed by substrate addition and measured after 10 mins by scintillation proximity assay B 7.13 pIC50 74 nM IC50 Bioorg Med Chem (2016) 24: 5702-5716 [PMID:27713015]
ChEMBL Inhibition of recombinant human PDE4B2 expressed in African green monkey COS7 cells using cAMP as substrate B 7.52 pIC50 30 nM IC50 J Med Chem (2018) 61: 2472-2489 [PMID:29502405]
ChEMBL Inhibition of PDE4B (unknown origin) B 7.57 pIC50 27 nM IC50 Eur J Med Chem (2019) 174: 198-215 [PMID:31035240]
GtoPdb Potency against recombinant human PDE4B1 and B2 isoforms in a TR-FRET assay. - 7.57 pIC50 27 nM IC50 Cell Signal (2014) 26: 2016-29 [PMID:24882690]
phosphodiesterase 4D/Phosphodiesterase 4D in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL288] [GtoPdb: 1303] [UniProtKB: Q08499]
ChEMBL Inhibition of PDE4D2 (unknown origin) B 6.27 pIC50 540 nM IC50 J Med Chem (2020) 63: 3370-3380 [PMID:32115956]
ChEMBL Inhibition of PDE4D (unknown origin) using cAMP as substrate B 7.13 pIC50 74 nM IC50 J Med Chem (2019) 62: 5579-5593 [PMID:31099559]
ChEMBL Inhibition of human PDE4D catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 (DE3) cells using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay B 7.32 pIC50 47.6 nM IC50 J Nat Prod (2020) 83: 1229-1237 [PMID:32100544]
GtoPdb Potency against recombinant human PDE4D2 isoform in a TR-FRET assay. - 7.48 pIC50 33 nM IC50 Cell Signal (2014) 26: 2016-29 [PMID:24882690]
ChEMBL Inhibition of PDE4D (unknown origin) B 7.48 pIC50 33 nM IC50 Eur J Med Chem (2019) 174: 198-215 [PMID:31035240]
phosphodiesterase 4A in Human [GtoPdb: 1300] [UniProtKB: P27815]
GtoPdb Potency against recombinant human PDE4A1A isoform in a TR-FRET assay. - 7.85 pIC50 14 nM IC50 Cell Signal (2014) 26: 2016-29 [PMID:24882690]
phosphodiesterase 4C in Human [GtoPdb: 1302] [UniProtKB: Q08493]
GtoPdb Potency against recombinant human PDE4C1 isoform in a TR-FRET assay. - 6.93 pIC50 118 nM IC50 Cell Signal (2014) 26: 2016-29 [PMID:24882690]

ChEMBL data shown on this page come from version 33:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]